EUVIMEDEUVIMED entdecken
Fallbericht

Clinical Heterogeneity and Long‐Term Outcomes of Pediatric Gastrointestinal Stromal Tumors: A Series of Four Patients Highlighting SDH‐Deficient and SDH‐Intact Subtypes

Hala Elfarraj, Maha Barbar iD, Iyad Sultan, Hadeel Halalsheh iD

Pediatric Blood & Cancer · 2026-10 · 73 (10)

DOI: 10.1002/1545-5017.70453 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 03.08.2026. Verfasst von Hala Elfarraj und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, King Hussein Cancer Center, Amman, Jordan. Hauptthemen laut MEDLINE: Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors, Succinate Dehydrogenase. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pediatric gastrointestinal stromal tumors (GISTs) are rare, often lacking KIT or platelet‐derived growth factor receptor‐alpha ( PDGFRA ) mutations and driven by succinate dehydrogenase (SDH) deficiency. We report four pediatric patients (three females and one male) managed over a 19‐year period. Two female patients had SDH‐deficient tumors; one suffered metastatic relapse, illustrating the recurrent clinical course of this subtype. Of the two remaining cases, one SDH‐intact female remains in remission 8 years post‐diagnosis. The male patient demonstrated imatinib resistance but responded to sunitinib, facilitating gastrectomy. Despite a local recurrence managed by secondary wedge resection, he remains in remission. Comprehensive molecular profiling is essential for navigating GIST's clinical heterogeneity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal NeoplasmsGastrointestinal Stromal TumorsSuccinate DehydrogenaseAdolescentChildFemaleHumansMaleImatinib Mesylate

Stichwörter der Autor:innen

gastrointestinal stromal tumorspediatric oncologyplatelet‐derived growth factor receptor‐alpha (PDGFRA)succinate dehydrogenase (SDH)tyrosine kinase inhibitors

Substanzen

Imatinib MesylateSuccinate Dehydrogenase

Autor:innen und Institutionen

  • Department of Pediatrics, King Hussein Cancer Center, Amman, Jordan.
  • Department of Pediatrics, The University of Jordan, Amman, Jordan.
  • Artificial Intelligence Office, King Hussein Cancer Center, Amman, Jordan.

ORCID-Profile: Maha Barbar, Hadeel Halalsheh

Zitieren

APA

Elfarraj, H., Barbar, M., Sultan, I., & Halalsheh, H. (2026). Clinical Heterogeneity and Long‐Term Outcomes of Pediatric Gastrointestinal Stromal Tumors: A Series of Four Patients Highlighting SDH‐Deficient and SDH‐Intact Subtypes. Pediatric Blood & Cancer, 73(10). https://doi.org/10.1002/1545-5017.70453

Vancouver

Elfarraj H, Barbar M, Sultan I, Halalsheh H. Clinical Heterogeneity and Long‐Term Outcomes of Pediatric Gastrointestinal Stromal Tumors: A Series of Four Patients Highlighting SDH‐Deficient and SDH‐Intact Subtypes. Pediatric Blood & Cancer. 2026;73(10). doi:10.1002/1545-5017.70453

BibTeX
@article{Elfarraj2026,
  author = {Elfarraj, Hala and Barbar, Maha and Sultan, Iyad and Halalsheh, Hadeel},
  title = {Clinical Heterogeneity and Long‐Term Outcomes of Pediatric Gastrointestinal Stromal Tumors: A Series of Four Patients Highlighting SDH‐Deficient and SDH‐Intact Subtypes},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  volume = {73},
  number = {10},
  doi = {10.1002/1545-5017.70453}
}
Kostenlos starten →